Marble Harbor Investment Counsel’s Edwards Lifesciences EW Stock Holding History

Marble Harbor Investment Counsel’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.69M	Sell	58,611 -1,130	-2%	-$93.2K	0.51%	49
2025 Q4	$5.09M	Hold	59,741	–	–	0.54%	45
2025 Q3	$4.65M	Hold	59,741	–	–	0.49%	48
2025 Q2	$4.67M	Sell	59,741 -3,033	-5%	-$226K	0.51%	47
2025 Q1	$4.55M	Sell	62,774 -5,647	-8%	-$404K	0.51%	43
2024 Q4	$5.07M	Sell	68,421 -1,064	-2%	-$74.5K	0.56%	43
2024 Q3	$4.59M	Sell	69,485 -4,115	-6%	-$299K	0.5%	46
2024 Q2	$6.8M	Buy	73,600 +260	+0.4%	+$23K	0.8%	37
2024 Q1	$7.01M	Sell	73,340 -605	-0.8%	-$50.8K	0.81%	39
2023 Q4	$5.64M	Buy	73,945 +75	+0.1%	+$5.22K	0.69%	41
2023 Q3	$5.12M	Buy	73,870 +1,165	+2%	+$93.6K	0.67%	42
2023 Q2	$6.86M	Sell	72,705 -600	-0.8%	-$52.1K	0.86%	38
2023 Q1	$6.06M	Hold	73,305	–	–	0.79%	40
2022 Q4	$5.47M	Buy	73,305 +4,255	+6%	+$328K	0.74%	40
2022 Q3	$5.71M	Buy	69,050 +175	+0.3%	+$16.8K	0.87%	36
2022 Q2	$6.55M	Buy	68,875 +150	+0.2%	+$15.5K	1%	31
2022 Q1	$8.09M	Sell	68,725 -840	-1%	-$94.2K	1.01%	28
2021 Q4	$9.01M	Buy	69,565 +22,655	+48%	+$2.64M	1.05%	28
2021 Q3	$5.31M	Sell	46,910 -26,700	-36%	-$3.05M	0.72%	39
2021 Q2	$7.62M	Hold	73,610	–	–	0.98%	30
2021 Q1	$6.16M	Sell	73,610 -515	-0.7%	-$43.5K	0.84%	35
2020 Q4	$6.76M	Buy	74,125 +3,200	+5%	+$265K	1%	30
2020 Q3	$5.66M	Sell	70,925 -100	-0.1%	-$7.8K	0.93%	32
2020 Q2	$4.91M	Sell	71,025 -900	-1%	-$64K	0.85%	36
2020 Q1	$4.52M	Sell	71,925 -2,175	-3%	-$157K	0.89%	35
2019 Q4	$5.76M	Sell	74,100 -120	-0.2%	-$9.37K	0.91%	36
2019 Q3	$5.44M	Sell	74,220 -600	-0.8%	-$42.1K	0.97%	35
2019 Q2	$4.61M	Buy	74,820 +900	+1%	+$54.4K	0.8%	39
2019 Q1	$4.71M	Sell	73,920 -900	-1%	-$51.4K	0.84%	37
2018 Q4	$3.82M	Buy	74,820 +120	+0.2%	+$6.07K	0.76%	41
2018 Q3	$4.33M	Hold	74,700	–	–	0.77%	42
2018 Q2	$3.63M	Sell	74,700 -1,800	-2%	-$84K	0.69%	43
2018 Q1	$3.56M	Sell	76,500 -900	-1%	-$39.1K	0.7%	41
2017 Q4	$2.91M	Sell	77,400 -600	-0.8%	-$22K	0.57%	49
2017 Q3	$2.84M	Hold	78,000	–	–	0.58%	47
2017 Q2	$3.07M	Buy	78,000 +600	+0.8%	+$21.9K	0.67%	43
2017 Q1	$2.43M	Hold	77,400	–	–	0.53%	49
2016 Q4	$2.42M	Sell	77,400 -120	-0.2%	-$3.89K	0.54%	48
2016 Q3	$3.12M	Sell	77,520 -480	-0.6%	-$18.1K	0.73%	40
2016 Q2	$2.59M	Hold	78,000	–	–	0.63%	45
2016 Q1	$2.29M	Hold	78,000	–	–	0.57%	50
2015 Q4	$2.05M	Hold	78,000	–	–	0.55%	47
2015 Q3	$1.85M	Hold	78,000	–	–	0.51%	50
2015 Q2	$1.85M	Hold	78,000	–	–	0.47%	53
2015 Q1	$1.85M	Sell	78,000 -600	-0.8%	-$13.5K	0.46%	53
2014 Q4	$1.67M	Hold	78,600	–	–	0.38%	57
2014 Q3	$1.34M	Hold	78,600	–	–	0.32%	59
2014 Q2	$1.13M	Sell	78,600 -8,400	-10%	-$114K	0.27%	68
2014 Q1	$1.07M	Hold	87,000	–	–	0.28%	67
2013 Q4	$954K	Hold	87,000	–	–	0.25%	69
2013 Q3	$1.01M	Hold	87,000	–	–	0.29%	65
2013 Q2	$974K	Buy	+87,000	New	+$1.03M	0.29%	65

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Marble Harbor Investment Counsel's EW Position: Q1 2026 in Review

Marble Harbor Investment Counsel reduced its Edwards Lifesciences (EW) stake by 1.9% in Q1 2026, selling an estimated $93.2K and leaving 58,611 shares worth $4.69M. The position accounts for 0.51% of the portfolio, ranked #49.

Marble Harbor Investment Counsel first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.01M in Q4 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Marble Harbor Investment Counsel held 58,611 shares of Edwards Lifesciences worth $4.69M as of Q1 2026.
Marble Harbor Investment Counsel sold 1,130 Edwards Lifesciences shares in Q1 2026, an estimated $93.2K.
Edwards Lifesciences made up 0.51% of Marble Harbor Investment Counsel's portfolio in Q1 2026, its #49 holding.
Marble Harbor Investment Counsel first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
Marble Harbor Investment Counsel's Edwards Lifesciences position peaked at $9.01M in Q4 2021.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Marble Harbor Investment Counsel's 13F filing for Q1 2026, filed 8 May 2026.